RU2008147791A - PHARMACEUTICAL COMPOSITION BASED ON CYCLOPHERON OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF PURULENT AND DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune Deficiency Conditions - Google Patents
PHARMACEUTICAL COMPOSITION BASED ON CYCLOPHERON OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF PURULENT AND DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune Deficiency Conditions Download PDFInfo
- Publication number
- RU2008147791A RU2008147791A RU2008147791/15A RU2008147791A RU2008147791A RU 2008147791 A RU2008147791 A RU 2008147791A RU 2008147791/15 A RU2008147791/15 A RU 2008147791/15A RU 2008147791 A RU2008147791 A RU 2008147791A RU 2008147791 A RU2008147791 A RU 2008147791A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- cycloferon
- substances selected
- series
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 28
- 201000010099 disease Diseases 0.000 title claims abstract 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract 6
- 230000009885 systemic effect Effects 0.000 title claims abstract 5
- UOMKBIIXHQIERR-UHFFFAOYSA-N cridanimod Chemical compound C1=CC=C2N(CC(=O)O)C3=CC=CC=C3C(=O)C2=C1 UOMKBIIXHQIERR-UHFFFAOYSA-N 0.000 title abstract 6
- 230000007812 deficiency Effects 0.000 title 1
- 230000001066 destructive effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 17
- 239000000203 mixture Substances 0.000 claims abstract 8
- 239000000829 suppository Substances 0.000 claims abstract 8
- 241000894006 Bacteria Species 0.000 claims abstract 5
- 239000000654 additive Substances 0.000 claims abstract 5
- 230000003444 anaesthetic effect Effects 0.000 claims abstract 5
- 230000000202 analgesic effect Effects 0.000 claims abstract 5
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract 5
- 230000001857 anti-mycotic effect Effects 0.000 claims abstract 5
- 239000002543 antimycotic Substances 0.000 claims abstract 5
- 239000003963 antioxidant agent Substances 0.000 claims abstract 5
- 230000003078 antioxidant effect Effects 0.000 claims abstract 5
- 239000002955 immunomodulating agent Substances 0.000 claims abstract 5
- 229940121354 immunomodulator Drugs 0.000 claims abstract 5
- 230000002584 immunomodulator Effects 0.000 claims abstract 5
- 239000003755 preservative agent Substances 0.000 claims abstract 5
- 230000002335 preservative effect Effects 0.000 claims abstract 5
- 229940088594 vitamin Drugs 0.000 claims abstract 5
- 235000013343 vitamin Nutrition 0.000 claims abstract 5
- 239000011782 vitamin Substances 0.000 claims abstract 5
- 229930003231 vitamin Natural products 0.000 claims abstract 5
- 206010061598 Immunodeficiency Diseases 0.000 claims abstract 4
- 208000029462 Immunodeficiency disease Diseases 0.000 claims abstract 4
- 230000000996 additive effect Effects 0.000 claims abstract 4
- 230000007813 immunodeficiency Effects 0.000 claims abstract 4
- 230000003902 lesion Effects 0.000 claims abstract 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract 4
- 230000000035 biogenic effect Effects 0.000 claims abstract 3
- 239000002775 capsule Substances 0.000 claims abstract 3
- 239000006071 cream Substances 0.000 claims abstract 3
- 239000003599 detergent Substances 0.000 claims abstract 3
- 239000000839 emulsion Substances 0.000 claims abstract 3
- 239000000499 gel Substances 0.000 claims abstract 3
- 239000002674 ointment Substances 0.000 claims abstract 3
- 239000003381 stabilizer Substances 0.000 claims abstract 3
- 239000000725 suspension Substances 0.000 claims abstract 3
- 239000007788 liquid Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- 210000004877 mucosa Anatomy 0.000 claims abstract 2
- 210000004400 mucous membrane Anatomy 0.000 claims abstract 2
- 235000015097 nutrients Nutrition 0.000 claims abstract 2
- FQMLTEAEJZVTAJ-UHFFFAOYSA-M sodium;2-(9-oxoacridin-10-yl)acetate Chemical compound [Na+].C1=CC=C2N(CC(=O)[O-])C3=CC=CC=C3C(=O)C2=C1 FQMLTEAEJZVTAJ-UHFFFAOYSA-M 0.000 claims 6
- 235000006708 antioxidants Nutrition 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- -1 myelonide Proteins 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 2
- 229920000053 polysorbate 80 Polymers 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- UPCOSYBELNEQAU-UHFFFAOYSA-L (2-decoxy-2-oxoethyl)-[2-[(2-decoxy-2-oxoethyl)-dimethylazaniumyl]ethyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCOC(=O)C[N+](C)(C)CC[N+](C)(C)CC(=O)OCCCCCCCCCC UPCOSYBELNEQAU-UHFFFAOYSA-L 0.000 claims 1
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 claims 1
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims 1
- VEPZOLKTNZOTTQ-UHFFFAOYSA-N 1-butyl-n-(2,4,6-trimethylphenyl)pyrrolidine-2-carboxamide Chemical compound CCCCN1CCCC1C(=O)NC1=C(C)C=C(C)C=C1C VEPZOLKTNZOTTQ-UHFFFAOYSA-N 0.000 claims 1
- CRWIVQWPUFWSCJ-UHFFFAOYSA-N 2-[(6-amino-7h-purin-8-yl)amino]ethanol Chemical compound NC1=NC=NC2=C1NC(NCCO)=N2 CRWIVQWPUFWSCJ-UHFFFAOYSA-N 0.000 claims 1
- YUXPJMWDDQCARU-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-(2-methylphenoxy)acetic acid Chemical compound OCCN(CCO)CCO.CC1=CC=CC=C1OCC(O)=O YUXPJMWDDQCARU-UHFFFAOYSA-N 0.000 claims 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 1
- 108010053070 Glutathione Disulfide Proteins 0.000 claims 1
- 102000000588 Interleukin-2 Human genes 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims 1
- 102000016943 Muramidase Human genes 0.000 claims 1
- 108010014251 Muramidase Proteins 0.000 claims 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims 1
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 1
- 229960002079 calcium pantothenate Drugs 0.000 claims 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 claims 1
- 229960001747 cinchocaine Drugs 0.000 claims 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 claims 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims 1
- 229960004022 clotrimazole Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- DRFILBXQKYDTFW-JIWRMXRASA-L disodium;2-[[(2r)-2-[[(4s)-4-amino-4-carboxybutanoyl]amino]-3-[[(2r)-2-[[(4s)-4-amino-4-carboxybutanoyl]amino]-3-(carboxylatomethylamino)-3-oxopropyl]disulfanyl]propanoyl]amino]acetate Chemical compound [Na+].[Na+].OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC([O-])=O)CSSC[C@@H](C(=O)NCC([O-])=O)NC(=O)CC[C@H](N)C(O)=O DRFILBXQKYDTFW-JIWRMXRASA-L 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- JPGDYIGSCHWQCC-UHFFFAOYSA-N emoxypine Chemical compound CCC1=NC(C)=CC=C1O JPGDYIGSCHWQCC-UHFFFAOYSA-N 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 229960004675 fusidic acid Drugs 0.000 claims 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 claims 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 claims 1
- 108010068227 glutoxim Proteins 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 239000000865 liniment Substances 0.000 claims 1
- 229940040145 liniment Drugs 0.000 claims 1
- 239000008297 liquid dosage form Substances 0.000 claims 1
- 108010013286 lysoamidase Proteins 0.000 claims 1
- 235000010335 lysozyme Nutrition 0.000 claims 1
- 229960000274 lysozyme Drugs 0.000 claims 1
- 239000004325 lysozyme Substances 0.000 claims 1
- 229910052748 manganese Inorganic materials 0.000 claims 1
- 239000011572 manganese Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 claims 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 1
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 claims 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 claims 1
- 229920005617 polyoxidonium Polymers 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- RVJVDCVIJCBUTH-UHFFFAOYSA-M sodium;5-amino-2h-phthalazin-3-ide-1,4-dione Chemical compound [Na+].O=C1N[N-]C(=O)C2=C1C(N)=CC=C2 RVJVDCVIJCBUTH-UHFFFAOYSA-M 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 1
- 108010015893 thymohexin Proteins 0.000 claims 1
- 229940042585 tocopherol acetate Drugs 0.000 claims 1
- 229960004380 tramadol Drugs 0.000 claims 1
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims 1
- GOZBHBFUQHMKQB-UHFFFAOYSA-N trimecaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=C(C)C=C1C GOZBHBFUQHMKQB-UHFFFAOYSA-N 0.000 claims 1
- 229950002569 trimecaine Drugs 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция местного и наружного применения для лечения гнойно-деструктивных поражений слизистой и кожи, общесистемных заболеваний при иммунодефицитных состояниях, содержащая циклоферон и основу, отличающаяся тем, что композиция выполнена в виде суспензии, эмульсии, крема, геля, нежидкой мази, или в виде суппозиториев, или капсул для ректального или вагинального применения при следующем соотношении компонентов, мас.%: ! циклоферон 0,00001-25,0 основа остальное! при этом может быть гидрофильной, липофильной или дифильной. ! 2. Фармацевтическая композиция на основе циклоферона местного и наружного применения для лечения гнойно-деструктивных поражений слизистой и кожи, а также общесистемных заболеваний при иммунодефицитных состояниях, содержащая циклоферон, целевую добавку и основу, отличающаяся тем, что она содержит в качестве целевой добавки вещество, выбранное из ряда: иммуномодулятор, вещество, обладающее антибактериальной активностью в отношении грамположительных и/или грамотрицательных бактерий, антимикотик, анестетик, стимулятор репаративных процессов, антиоксидант, биогенный элемент, анальгетик, витамин, консервант или их смесь при следующем содержании компонентов, мас.%: ! циклоферон 0,00001-25,00 вещество, обладающее антибактериальной активностью в отношении грамположительных и грамотрицательных бактерий 0,01-3,00 антимикотик 0,50-3,00 анестетик 0,50-4,00 стимулятор репаративных процессов 0,50-4,00 антиоксидант 0,001-1,00 биогенный элемент 0,000001-5,5 иммуномодулятор 0,000005-25,0 анальгетик 0,10-30,00 витамин 0,30-5,00 консервант 0,05-5,00 стабилизатор 0,001-2,00 неионогенный детергент 0,001-0,10 солюб� 1. A pharmaceutical composition for local and external use for the treatment of purulent-destructive lesions of the mucosa and skin, systemic diseases in immunodeficiency conditions, containing cycloferon and a base, characterized in that the composition is in the form of a suspension, emulsion, cream, gel, non-liquid ointment, or in the form of suppositories, or capsules for rectal or vaginal administration in the following ratio of components, wt.%:! cycloferon 0.00001-25.0 basis rest! it may be hydrophilic, lipophilic or diphilic. ! 2. A pharmaceutical composition based on local and external cycloferon for the treatment of purulent-destructive lesions of the mucous membrane and skin, as well as systemic diseases in immunodeficiency conditions, containing cycloferon, a target additive and a base, characterized in that it contains a substance selected as the target additive from the series: immunomodulator, a substance with antibacterial activity against gram-positive and / or gram-negative bacteria, antimycotic, anesthetic, reparative stimulant ess, antioxidant, biogenic element, analgesic, vitamin, preservative or their mixture with the following components, wt.%:! cycloferon 0.00001-25.00 substance with antibacterial activity against gram-positive and gram-negative bacteria 0.01-3.00 antimycotic 0.50-3.00 anesthetic 0.50-4.00 stimulant of reparative processes 0.50-4 , 00 antioxidant 0.001-1.00 nutrient 0.000001-5.5 immunomodulator 0.000005-25.0 analgesic 0.10-30.00 vitamin 0.30-5.00 preservative 0.05-5.00 stabilizer 0.001-2.00 nonionic detergent 0.001-0.10 solub
Claims (25)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008147791/15A RU2414221C2 (en) | 2008-12-04 | 2008-12-04 | Cyclopherone-based pharmaceutical composition of local or external application for treatment of purulent-destructive affection of mucous membrane and skin, general-system diseases in case of immunodeficiency conditions (versions) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008147791/15A RU2414221C2 (en) | 2008-12-04 | 2008-12-04 | Cyclopherone-based pharmaceutical composition of local or external application for treatment of purulent-destructive affection of mucous membrane and skin, general-system diseases in case of immunodeficiency conditions (versions) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008147791A true RU2008147791A (en) | 2010-06-10 |
| RU2414221C2 RU2414221C2 (en) | 2011-03-20 |
Family
ID=42681261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008147791/15A RU2414221C2 (en) | 2008-12-04 | 2008-12-04 | Cyclopherone-based pharmaceutical composition of local or external application for treatment of purulent-destructive affection of mucous membrane and skin, general-system diseases in case of immunodeficiency conditions (versions) |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2414221C2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2470640C1 (en) * | 2011-04-15 | 2012-12-27 | Учреждение Российской академии наук Институт органического синтеза им. И.Я. Постовского Уральского отделения РАН | Agent for treating inflammatory oral diseases and method of treating inflammatory oral diseases |
| RU2521272C1 (en) * | 2013-03-19 | 2014-06-27 | Федеральное государственное бюджетное учреждение науки Институт биомедицинских исследований Владикавказского научного центра РАН и правительства РСО-Алания (ИБМИ ВНЦ РАН и РСО-А) | Drug preparation in suppositories for infectious-inflammatory disorders caused by type 1 herpes simplex and cytomegalovirus, and method for using it for treating children |
| RU2624234C1 (en) * | 2015-12-30 | 2017-07-03 | Федеральное государственное бюджетное учреждение "Научно-клинический центр оториноларингологии Федерального медико-биологического агентства России" (ФГБУ НКЦО ФМБА России) | Method for complications prevention in postoperative period during surgical treatment of nasal polyposis |
| RU2655808C2 (en) * | 2016-10-11 | 2018-05-29 | Закрытое Акционерное Общество "Биологические Исследования И Системы" (Зао "Бис") | Pharmaceutical combined composition for local and external use on basis of bacteriolytic and proteolytic complex of enzymes |
| CN109819650A (en) * | 2017-09-25 | 2019-05-28 | 春布里泽·格奥尔基·格奥尔基耶维奇 | Thermostable compositions with antiviral and antibacterial activity and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2114611C1 (en) * | 1995-12-21 | 1998-07-10 | Валентина Васильевна Малиновская | Ointment |
| RU2147873C1 (en) * | 1999-06-11 | 2000-04-27 | Григорян Седа Суреновна | Suppositories and method of prophylaxis and treatment of diseases transmitted by genital tracts |
-
2008
- 2008-12-04 RU RU2008147791/15A patent/RU2414221C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2414221C2 (en) | 2011-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008147791A (en) | PHARMACEUTICAL COMPOSITION BASED ON CYCLOPHERON OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF PURULENT AND DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune Deficiency Conditions | |
| RU2016139698A (en) | Pharmaceutical combination composition for local and external use on the basis of dioxidine | |
| JP7378409B2 (en) | Emulsions for topical treatment of skin and mucous membrane infections | |
| RU2008147792A (en) | PHARMACEUTICAL COMPOSITION BASED ON ACID ACIDONE ACID ACID AND ITS COMPOUNDS FOR TREATMENT OF PURULENT DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune-Deficient | |
| RU2008147790A (en) | PHARMACEUTICAL COMPOSITION BASED ON TILORONES OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF PURULENT DESTRUCTIVE DISEASES OF MUCH AND SKIN, GENERAL DISEASES IN IMMUNO DEFICIENCY CONDITIONS | |
| RU2016139699A (en) | Pharmaceutical combination composition for local and external use based on bacteriolytic and proteolytic complex of enzymes | |
| CN104069124B (en) | Compositions and preparation for gynecological infection | |
| US20030064103A1 (en) | Compositions and methods for treating vulvovaginitis and vaginosis | |
| US3985873A (en) | Solution containing trimethoprim, sulfacetamide and polymyxin | |
| RU2007144167A (en) | BIOLOGICALLY ACTIVE FOOD ADDITIVE | |
| RU2006131812A (en) | PHARMACEUTICAL COMPOSITION OF ANTI-INFLAMMATORY AND ANTIMICROBIC ACTION IN THE FORM OF OILS ON A HYDROPHOBIC BASIS FOR TREATMENT OF SKIN DISEASES (OPTIONS) | |
| RU2010134748A (en) | DRUG FOR CORRECTION OF EXCHANGE PROCESSES AND IMPROVEMENT OF NATURAL RESISTANCE OF ANIMAL ORGANISM | |
| RU2007140813A (en) | PHARMACEUTICAL DRUG FOR EXTERNAL USE ON THE BASIS OF STEFAGLABRIN | |
| RU2360667C2 (en) | Antibacterial medication for treatment and prevention of gastro-intestinal diseases in animals | |
| RU2007140811A (en) | PHARMACEUTICAL PRODUCT FOR OUTDOOR AND LOCAL USE ON THE BASIS OF STEFAGLABRIN | |
| CN107823132A (en) | A kind of Marbofloxacin suspension and preparation method thereof | |
| RU2008122166A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS | |
| RU2011134414A (en) | FULVIC ACID COMBINATION FOR TREATMENT OF VARIOUS CONDITIONS AND DISEASES | |
| RU2007127815A (en) | SUPPOSITORIES OF COMBINED ACTION FOR TREATMENT OF INFECTIOUS GYNECOLOGICAL DISEASES (OPTIONS) | |
| RU2005104747A (en) | THE DRUG FOR THE TREATMENT OF POST-UNIVERSAL PURULAR-CATARAL ENDOMETRITIS AND MASTITIS IN COWS AND METHODS OF ITS APPLICATION | |
| RU2711195C1 (en) | Method of treating mastitis in animals | |
| RU2205011C1 (en) | Pharmaceutical composition eliciting antibacterial activity | |
| RU2007136331A (en) | PHARMACEUTICAL DRUG FOR OUTDOOR AND LOCAL USE ON THE BASIS OF SIGETINE | |
| RU2762088C1 (en) | Method for treating mastitis in cows | |
| RU2574953C1 (en) | Agent for treating and preventing viral skin new growths |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201205 |